Dougherty Michael R
SEC-identified person · CIK 1033516 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Trevena INC TRVN | Director | filed 2014 - 2023 |
| Idera Pharmaceuticals, INC. IDRA | Director | filed 2019 - 2023 |
| Marinus Pharmaceuticals, INC. NASDAQMRNS | Director | filed 2017 - 2022 |
| Foundation Medicine, Inc. FMI | Director | filed 2016 - 2018 |
| Vaxart, Inc. VXRT | Director | filed 2013 - 2017 |
| Melinta Therapeutics, INC. /NEW/ MLNT | Director | filed 2013 - 2017 |
| Celator Pharmaceuticals Inc CPXX | Director · Executive Chairman | filed 2013 - 2016 |
| Viropharma INC VPHM | Director | filed 2006 - 2014 |
| Adolor Corp adlr | Director · SVP & Chief Operating Officer | filed 2006 - 2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.